The escalating threat of antimicrobial resistance (AMR) is driving a critical expansion in the diagnostic sector, as healthcare providers seek faster and more accurate ways to determine effective treatments. The Antimicrobial Susceptibility Testing Market was valued at USD 4.24 billion in 2024 and is expected to reach USD 6.68 billion by 2032, growing at a CAGR of...

The escalating threat of antimicrobial resistance (AMR) is driving a critical expansion in the diagnostic sector, as healthcare providers seek faster and more accurate ways to determine effective treatments. The Antimicrobial Susceptibility Testing Market was valued at USD 4.24 billion in 2024 and is expected to reach USD 6.68 billion by 2032, growing at a CAGR of...

The escalating threat of antimicrobial resistance (AMR) is driving a critical expansion in the diagnostic sector, as healthcare providers seek faster and more accurate ways to determine effective treatments. The Antimicrobial Susceptibility Testing Market was valued at USD 4.24 billion in 2024 and is expected to reach USD 6.68 billion by 2032, growing at a CAGR of...

"Executive Summary Antimicrobial Susceptibility Testing Market Size and Share: Global Industry Snapshot Antimicrobial susceptibility testing market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 5.9% in the forecast period of 2022 to 2029 and is expected to reach USD 5,688.50...

"Executive Summary Antimicrobial Susceptibility Testing Market Size and Share: Global Industry Snapshot Antimicrobial susceptibility testing market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 5.9% in the forecast period of 2022 to 2029 and is expected to reach USD 5,688.50...

Antimicrobial Susceptibility Testing Market Summary The global antimicrobial susceptibility testing market size was estimated at USD 3.42 billion in 2022 and is projected to reach USD 5.08 billion by 2030, growing at a CAGR of 5.1% from 2023 to 2030. This moderate yet steady growth reflects the increasing clinical importance of accurately identifying effective antimicrobial therapies....